These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9661205)

  • 1. Building the proper foundation for genomics-based patents.
    Chahine KG
    Nat Biotechnol; 1998 Jul; 16(7):683-5. PubMed ID: 9661205
    [No Abstract]   [Full Text] [Related]  

  • 2. The challenge to patent law of pure chemical protein synthesis.
    Fellmeth AX
    Nat Biotechnol; 2005 May; 23(5):547-9. PubMed ID: 15877067
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA patent decision leaves questions for diagnostics.
    Harrison C
    Nat Rev Drug Discov; 2011 Aug; 10(9):650-1. PubMed ID: 21878971
    [No Abstract]   [Full Text] [Related]  

  • 4. [Structural proteomics and patents].
    Sumikura K
    Tanpakushitsu Kakusan Koso; 2002 Jun; 47(8 Suppl):967-72. PubMed ID: 12099048
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2008 Nov; 7(11):882-3. PubMed ID: 18974746
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of the Hatch-Waxman Act and its impact on the drug development process.
    Mossinghoff GJ
    Food Drug Law J; 1999; 54(2):187-94. PubMed ID: 11758572
    [No Abstract]   [Full Text] [Related]  

  • 7. Navigating the Hatch-Waxman Act's safe harbor.
    Jones PB
    Food Drug Law J; 2002; 57(3):475-89. PubMed ID: 12710407
    [No Abstract]   [Full Text] [Related]  

  • 8. Old drugs, new uses: solving a Hatch-Waxman patent predicament.
    McPhie DC
    Food Drug Law J; 2004; 59(1):155-68. PubMed ID: 15190929
    [No Abstract]   [Full Text] [Related]  

  • 9. Reach-through claims for drug target patents: Rx for pharmaceutical policy.
    Bohrer RA
    Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA-based patents: an empirical analysis.
    Mills AE; Tereskerz P
    Nat Biotechnol; 2008 Sep; 26(9):993-5. PubMed ID: 18779808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent protection for protein structures and databases.
    Meyers TC; Turano TA; Greenhalgh DA; Waller PR
    Nat Struct Biol; 2000 Nov; 7 Suppl():950-2. PubMed ID: 11103996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 14. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 15. Patenting EPO analogs: screening vs. predictability.
    Kelly P
    Biotechnology (N Y); 1990 Feb; 8(2):112-3. PubMed ID: 1366357
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 17. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

  • 18. As a matter of scientific fact: applying the inherency doctrine in biotechnology.
    Moroz E; Schildkraut MJ
    Nat Biotechnol; 1997 Dec; 15(13):1403-4. PubMed ID: 9415895
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteomics. Gene and protein patents get ready to go head to head.
    Service RF
    Science; 2001 Dec; 294(5549):2082-3. PubMed ID: 11739934
    [No Abstract]   [Full Text] [Related]  

  • 20. Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing.
    Marques UR; Guimarães VS; Sternberg C
    Food Drug Law J; 2005; 60(3):471-7. PubMed ID: 16304752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.